Literature DB >> 3374538

Partial monosomy 21, diminished activity of superoxide dismutase, and pulmonary oxygen toxicity.

A D Ackerman1, J C Fackler, C M Tuck-Muller, M M Tarpey, B A Freeman, M C Rogers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3374538     DOI： 10.1056/NEJM198806233182506

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Necropsy findings in a fetus with a 46,XY,dic t(X;21)(p11.1;p11.1).

Authors:  N M Smith; H Fernandez; H M Chambers; D F Callen
Journal:  J Med Genet       Date:  1992-07       Impact factor: 6.318

Review 2.  Molecular biology and respiratory disease. I-- Basic principles.

Authors:  C A Owen; R A Stockley
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

3.  Molecular mapping of 21 features associated with partial monosomy 21: involvement of the APP-SOD1 region.

Authors:  Z Chettouh; M F Croquette; B Delobel; S Gilgenkrants; C Leonard; C Maunoury; M Prieur; M O Rethoré; P M Sinet; M Chery
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

4.  Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis.

Authors:  M E Ripps; G W Huntley; P R Hof; J H Morrison; J W Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

5.  Expression of LFA-1 by a lymphoblastoid cell line from a patient with monosomy 21: effects on intercellular adhesion.

Authors:  G M Taylor; D Braddock; A J Robson; W D Fergusson; D P Duckett; S W D'Souza; P Brenchley
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

Review 6.  Understanding the mechanisms of drug-associated interstitial lung disease.

Authors:  T Higenbottam; K Kuwano; B Nemery; Y Fujita
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.